Diagnostic Medical Systems SA Asset Resilience Ratio
Diagnostic Medical Systems SA asset resilience ratio. Diagnostic Medical Systems SA (ALDMS) has an Asset Resilience Ratio of 1.48% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Diagnostic Medical Systems SA defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Diagnostic Medical Systems SA (2012–2025)
Asset resilience ratio of Diagnostic Medical Systems SA from 2012 to 2025. This chart shows how Diagnostic Medical Systems SA's Asset Resilience Ratio has changed over time. Read Diagnostic Medical Systems SA total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Diagnostic Medical Systems SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Diagnostic Medical Systems SA assets under control.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €927.00K | 1.48% |
| Total Liquid Assets | €927.00K | 1.48% |
Asset Resilience Insights
- Limited Liquidity: Diagnostic Medical Systems SA maintains only 1.48% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Diagnostic Medical Systems SA Industry Peers by Asset Resilience Ratio
Compare Diagnostic Medical Systems SA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
T&L Co. Ltd
KQ:340570 |
Medical Devices | 26.03% |
|
Paxman AB
ST:PAX |
Medical Devices | -3.83% |
|
VIROMED MEDICAL NA O.N.
XETRA:VME |
Medical Devices | 0.03% |
|
Pulsenmore Ltd
TA:PULS |
Medical Devices | 51.61% |
|
Geratherm Medical AG
XETRA:GME |
Medical Devices | 34.89% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
Diagnostic Medical Systems SA Asset Resilience Ratio by Year (2012–2025)
Diagnostic Medical Systems SA asset resilience ratio by year from 2012 to 2025. The table below shows the annual Asset Resilience Ratio data for Diagnostic Medical Systems SA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 1.48% | €927.00K ≈ $1.08 Million |
€62.52 Million ≈ $73.09 Million |
+0.16pp |
| 2024-12-31 | 1.32% | €711.00K ≈ $831.23K |
€53.95 Million ≈ $63.07 Million |
-0.56pp |
| 2023-12-31 | 1.88% | €959.00K ≈ $1.12 Million |
€51.14 Million ≈ $59.79 Million |
+1.12pp |
| 2022-12-31 | 0.76% | €409.00K ≈ $478.16K |
€53.89 Million ≈ $63.01 Million |
+0.76pp |
| 2021-12-31 | 0.00% | €-1.00K ≈ $-1.17K |
€53.03 Million ≈ $62.00 Million |
0.00pp |
| 2020-12-31 | 0.00% | €1.00K ≈ $1.17K |
€45.80 Million ≈ $53.54 Million |
-7.65pp |
| 2018-12-31 | 7.66% | €2.82 Million ≈ $3.30 Million |
€36.84 Million ≈ $43.07 Million |
-8.09pp |
| 2017-12-31 | 15.74% | €6.31 Million ≈ $7.38 Million |
€40.08 Million ≈ $46.86 Million |
-5.64pp |
| 2016-12-31 | 21.38% | €10.69 Million ≈ $12.49 Million |
€49.98 Million ≈ $58.43 Million |
+17.01pp |
| 2015-12-31 | 4.37% | €2.03 Million ≈ $2.37 Million |
€46.42 Million ≈ $54.27 Million |
-8.32pp |
| 2014-12-31 | 12.69% | €5.00 Million ≈ $5.85 Million |
€39.40 Million ≈ $46.06 Million |
+12.44pp |
| 2013-12-31 | 0.25% | €59.00K ≈ $68.98K |
€23.57 Million ≈ $27.55 Million |
-6.45pp |
| 2012-12-31 | 6.70% | €1.55 Million ≈ $1.81 Million |
€23.16 Million ≈ $27.07 Million |
-- |
About Diagnostic Medical Systems SA
Diagnostic Medical Systems S.A. engages in the design, development, manufacture, and sale of medical imaging systems in France. It offers ADAM, in-house software suite; R and F solutions; bone densitometry; chest and bone room; mobile; c-arm; retrofit kit; and mammography equipment. The company was founded in 1979 and is headquartered in Gallargues-le-Montueux, France.